FHIR Release 3 (STU) 4

This page is part of the FHIR Specification (v3.0.2: (v4.0.1: R4 - Mixed Normative and STU 3). ) in it's permanent home (it will always be available at this URL). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R4 R3 R2

4.3.1.22 4.4.1.234 Value Set http://hl7.org/fhir/ValueSet/vaccine-code

Public Health and Emergency Response Work Group   Maturity Level : 1 Informative Draft Use Context : Not Intended for Production use Any

This is a value set defined by the FHIR project.

Summary

Defining URL: http://hl7.org/fhir/ValueSet/vaccine-code
Version: 4.0.1
Name: VaccineAdministeredValueSet
Title: Vaccine Administered Value Set
Definition:

This identifies the vaccine substance administered - CVX codes.

Committee: Public Health and Emergency Response Work Group
OID: 2.16.840.1.113883.3.88.12.80.22 (for OID based terminology systems)
Source Resource XML / JSON

This value set is used in the following places:

4.3.1.22.1 4.4.1.234.1 Content Logical Definition

This value set includes codes from the following code systems:

  • Include all codes defined in http://hl7.org/fhir/sid/cvx
  • Include all codes defined in urn:oid:1.2.36.1.2001.1005.17

 

4.3.1.22.2 4.4.1.234.2 Expansion

This expansion generated 19 Apr 2017 01 Nov 2019

This value set contains 239 268 concepts

Code System Display
01 143 http://hl7.org/fhir/sid/cvx DTP Adenovirus types 4 and 7
02 54 http://hl7.org/fhir/sid/cvx OPV adenovirus, type 4
03 55 http://hl7.org/fhir/sid/cvx MMR adenovirus, type 7
04 82 http://hl7.org/fhir/sid/cvx M/R adenovirus, unspecified formulation
05 24 http://hl7.org/fhir/sid/cvx measles anthrax
06 181 http://hl7.org/fhir/sid/cvx rubella anthrax immune globulin
07 801 http://hl7.org/fhir/sid/cvx mumps AS03 Adjuvant
08 19 http://hl7.org/fhir/sid/cvx Hep B, adolescent or pediatric BCG
09 27 http://hl7.org/fhir/sid/cvx Td (adult), adsorbed botulinum antitoxin
10 173 http://hl7.org/fhir/sid/cvx IPV cholera, BivWC
100 174 http://hl7.org/fhir/sid/cvx pneumococcal conjugate PCV 7 cholera, live attenuated
101 26 http://hl7.org/fhir/sid/cvx typhoid, ViCPs cholera, unspecified formulation
102 172 http://hl7.org/fhir/sid/cvx DTaP/DTP-Hib-Hep B cholera, WC-rBS
103 29 http://hl7.org/fhir/sid/cvx meningococcal C conjugate CMVIG
104 56 http://hl7.org/fhir/sid/cvx Hep A-Hep B dengue fever
12 http://hl7.org/fhir/sid/cvx diphtheria antitoxin
105 28 http://hl7.org/fhir/sid/cvx vaccinia (smallpox) diluted DT (pediatric)
20 http://hl7.org/fhir/sid/cvx DTaP
106 http://hl7.org/fhir/sid/cvx DTaP, 5 pertussis antigens
107 http://hl7.org/fhir/sid/cvx DTaP, unspecified formulation
108 146 http://hl7.org/fhir/sid/cvx meningococcal, unspecified formulation DTaP,IPV,Hib,HepB
109 110 http://hl7.org/fhir/sid/cvx pneumococcal, unspecified formulation DTaP-Hep B-IPV
11 50 http://hl7.org/fhir/sid/cvx pertussis DTaP-Hib
110 120 http://hl7.org/fhir/sid/cvx DTaP-Hep B-IPV DTaP-Hib-IPV
111 130 http://hl7.org/fhir/sid/cvx influenza, live, intranasal DTaP-IPV
112 132 http://hl7.org/fhir/sid/cvx tetanus toxoid, unspecified formulation DTaP-IPV-HIB-HEP B, historical
113 170 http://hl7.org/fhir/sid/cvx Td (adult) preservative free DTAP/IPV/HIB - non-US
114 01 http://hl7.org/fhir/sid/cvx meningococcal MCV4P DTP
115 22 http://hl7.org/fhir/sid/cvx Tdap DTP-Hib
116 102 http://hl7.org/fhir/sid/cvx rotavirus, pentavalent DTP-Hib-Hep B
117 57 http://hl7.org/fhir/sid/cvx VZIG (IND) hantavirus
118 30 http://hl7.org/fhir/sid/cvx HPV, bivalent HBIG
119 52 http://hl7.org/fhir/sid/cvx rotavirus, monovalent Hep A, adult
12 154 http://hl7.org/fhir/sid/cvx diphtheria antitoxin Hep A, IG
120 169 http://hl7.org/fhir/sid/cvx DTaP-Hib-IPV Hep A, live attenuated
121 83 http://hl7.org/fhir/sid/cvx zoster Hep A, ped/adol, 2 dose
84 http://hl7.org/fhir/sid/cvx Hep A, ped/adol, 3 dose
122 31 http://hl7.org/fhir/sid/cvx rotavirus, Hep A, pediatric, unspecified formulation
123 85 http://hl7.org/fhir/sid/cvx influenza, H5N1-1203 Hep A, unspecified formulation
125 104 http://hl7.org/fhir/sid/cvx Novel Influenza-H1N1-09, nasal Hep A-Hep B
126 193 http://hl7.org/fhir/sid/cvx Novel influenza-H1N1-09, preservative-free Hep A-Hep B, pediatric/adolescent
127 08 http://hl7.org/fhir/sid/cvx Novel influenza-H1N1-09 Hep B, adolescent or pediatric
42 http://hl7.org/fhir/sid/cvx Hep B, adolescent/high risk infant
128 43 http://hl7.org/fhir/sid/cvx Novel Influenza-H1N1-09, all formulations Hep B, adult
44 http://hl7.org/fhir/sid/cvx Hep B, dialysis
129 45 http://hl7.org/fhir/sid/cvx Japanese Encephalitis, Hep B, unspecified formulation
13 58 http://hl7.org/fhir/sid/cvx TIG Hep C
130 59 http://hl7.org/fhir/sid/cvx DTaP-IPV Hep E
131 189 http://hl7.org/fhir/sid/cvx typhus, historical HepB-CpG
132 60 http://hl7.org/fhir/sid/cvx DTaP-IPV-HIB-HEP B, historical herpes simplex 2
47 http://hl7.org/fhir/sid/cvx Hib (HbOC)
133 46 http://hl7.org/fhir/sid/cvx Pneumococcal conjugate PCV 13 Hib (PRP-D)
49 http://hl7.org/fhir/sid/cvx Hib (PRP-OMP)
134 48 http://hl7.org/fhir/sid/cvx Japanese Encephalitis IM Hib (PRP-T)
17 http://hl7.org/fhir/sid/cvx Hib, unspecified formulation
135 51 http://hl7.org/fhir/sid/cvx Influenza, high dose seasonal Hib-Hep B
61 http://hl7.org/fhir/sid/cvx HIV
136 118 http://hl7.org/fhir/sid/cvx Meningococcal MCV4O HPV, bivalent
62 http://hl7.org/fhir/sid/cvx HPV, quadrivalent
137 http://hl7.org/fhir/sid/cvx HPV, unspecified formulation
138 165 http://hl7.org/fhir/sid/cvx Td (adult) HPV9
86 http://hl7.org/fhir/sid/cvx IG
139 14 http://hl7.org/fhir/sid/cvx Td(adult) IG, unspecified formulation
87 http://hl7.org/fhir/sid/cvx IGIV
14 160 http://hl7.org/fhir/sid/cvx IG, Influenza A monovalent (H5N1), ADJUVANTED-2013
151 http://hl7.org/fhir/sid/cvx influenza nasal, unspecified formulation
123 http://hl7.org/fhir/sid/cvx influenza, H5N1-1203
140 135 http://hl7.org/fhir/sid/cvx Influenza, high dose seasonal
153 http://hl7.org/fhir/sid/cvx Influenza, seasonal, injectable, MDCK, preservative free
141 171 http://hl7.org/fhir/sid/cvx Influenza, seasonal, injectable injectable, MDCK, preservative free, quadrivalent
142 186 http://hl7.org/fhir/sid/cvx tetanus toxoid, not adsorbed Influenza, injectable, MDCK, quadrivalent, preservative
158 http://hl7.org/fhir/sid/cvx influenza, injectable, quadrivalent
143 150 http://hl7.org/fhir/sid/cvx Adenovirus types 4 and 7 influenza, injectable, quadrivalent, preservative free
161 http://hl7.org/fhir/sid/cvx Influenza, injectable,quadrivalent, preservative free, pediatric
144 166 http://hl7.org/fhir/sid/cvx influenza, seasonal, intradermal, quadrivalent, preservative free
145 111 http://hl7.org/fhir/sid/cvx RSV-MAb (new) influenza, live, intranasal
146 149 http://hl7.org/fhir/sid/cvx DTaP,IPV,Hib,HepB influenza, live, intranasal, quadrivalent
147 155 http://hl7.org/fhir/sid/cvx meningococcal MCV4, unspecified formulation influenza, recombinant, injectable, preservative free
185 http://hl7.org/fhir/sid/cvx influenza, recombinant, quadrivalent,injectable, preservative free
148 141 http://hl7.org/fhir/sid/cvx Meningococcal C/Y-HIB PRP Influenza, seasonal, injectable
140 http://hl7.org/fhir/sid/cvx Influenza, seasonal, injectable, preservative free
149 144 http://hl7.org/fhir/sid/cvx influenza, live, intranasal, quadrivalent seasonal, intradermal, preservative free
15 http://hl7.org/fhir/sid/cvx influenza, split (incl. purified surface antigen)
150 168 http://hl7.org/fhir/sid/cvx influenza, injectable, quadrivalent, preservative free trivalent, adjuvanted
151 88 http://hl7.org/fhir/sid/cvx influenza nasal, influenza, unspecified formulation
152 16 http://hl7.org/fhir/sid/cvx Pneumococcal Conjugate, unspecified formulation influenza, whole
153 10 http://hl7.org/fhir/sid/cvx Influenza, injectable, MDCK, preservative free IPV
154 134 http://hl7.org/fhir/sid/cvx Hep A, IG Japanese Encephalitis IM
155 39 http://hl7.org/fhir/sid/cvx influenza, recombinant, injectable, preservative free Japanese encephalitis SC
156 129 http://hl7.org/fhir/sid/cvx Rho(D)-IG Japanese Encephalitis, unspecified formulation
157 63 http://hl7.org/fhir/sid/cvx Rho(D) -IG IM Junin virus
64 http://hl7.org/fhir/sid/cvx leishmaniasis
158 65 http://hl7.org/fhir/sid/cvx influenza, injectable, quadrivalent leprosy
66 http://hl7.org/fhir/sid/cvx Lyme disease
159 04 http://hl7.org/fhir/sid/cvx Rho(D) - Unspecified formulation M/R
67 http://hl7.org/fhir/sid/cvx malaria
16 05 http://hl7.org/fhir/sid/cvx influenza, whole measles
68 http://hl7.org/fhir/sid/cvx melanoma
160 191 http://hl7.org/fhir/sid/cvx Influenza meningococcal A monovalent (H5N1), ADJUVANTED-2013 polysaccharide (non-US)
161 192 http://hl7.org/fhir/sid/cvx Influenza, injectable,quadrivalent, preservative free, pediatric meningococcal AC polysaccharide (non-US)
162 108 http://hl7.org/fhir/sid/cvx meningococcal B, recombinant ACWY, unspecified formulation
163 http://hl7.org/fhir/sid/cvx meningococcal B, OMV
164 162 http://hl7.org/fhir/sid/cvx meningococcal B, unspecified recombinant
17 164 http://hl7.org/fhir/sid/cvx Hib, meningococcal B, unspecified formulation
18 103 http://hl7.org/fhir/sid/cvx rabies, intramuscular injection meningococcal C conjugate
19 148 http://hl7.org/fhir/sid/cvx BCG Meningococcal C/Y-HIB PRP
20 147 http://hl7.org/fhir/sid/cvx DTaP meningococcal MCV4, unspecified formulation
21 136 http://hl7.org/fhir/sid/cvx varicella Meningococcal MCV4O
22 114 http://hl7.org/fhir/sid/cvx DTP-Hib meningococcal MCV4P
23 32 http://hl7.org/fhir/sid/cvx plague meningococcal MPSV4
24 167 http://hl7.org/fhir/sid/cvx anthrax meningococcal, unknown serogroups
25 03 http://hl7.org/fhir/sid/cvx typhoid, oral MMR
26 94 http://hl7.org/fhir/sid/cvx cholera MMRV
27 07 http://hl7.org/fhir/sid/cvx botulinum antitoxin mumps
28 127 http://hl7.org/fhir/sid/cvx DT (pediatric) Novel influenza-H1N1-09
29 128 http://hl7.org/fhir/sid/cvx CMVIG Novel Influenza-H1N1-09, all formulations
30 125 http://hl7.org/fhir/sid/cvx HBIG Novel Influenza-H1N1-09, nasal
31 126 http://hl7.org/fhir/sid/cvx Hep A, pediatric, unspecified formulation Novel influenza-H1N1-09, preservative-free
32 02 http://hl7.org/fhir/sid/cvx meningococcal MPSV4 OPV
33 179 http://hl7.org/fhir/sid/cvx pneumococcal polysaccharide PPV23 OPV ,monovalent, unspecified
34 178 http://hl7.org/fhir/sid/cvx RIG OPV bivalent
35 182 http://hl7.org/fhir/sid/cvx tetanus toxoid, adsorbed OPV, Unspecified
36 69 http://hl7.org/fhir/sid/cvx VZIG parainfluenza-3
37 177 http://hl7.org/fhir/sid/cvx yellow fever PCV10
38 11 http://hl7.org/fhir/sid/cvx rubella/mumps pertussis
39 23 http://hl7.org/fhir/sid/cvx Japanese encephalitis SC plague
40 133 http://hl7.org/fhir/sid/cvx rabies, intradermal injection Pneumococcal conjugate PCV 13
41 100 http://hl7.org/fhir/sid/cvx typhoid, parenteral pneumococcal conjugate PCV 7
42 152 http://hl7.org/fhir/sid/cvx Hep B, adolescent/high risk infant Pneumococcal Conjugate, unspecified formulation
43 33 http://hl7.org/fhir/sid/cvx Hep B, adult pneumococcal polysaccharide PPV23
44 109 http://hl7.org/fhir/sid/cvx Hep B, dialysis pneumococcal, unspecified formulation
45 89 http://hl7.org/fhir/sid/cvx Hep B, polio, unspecified formulation
46 70 http://hl7.org/fhir/sid/cvx Hib (PRP-D) Q fever
47 175 http://hl7.org/fhir/sid/cvx Hib (HbOC) Rabies - IM Diploid cell culture
48 176 http://hl7.org/fhir/sid/cvx Hib (PRP-T) Rabies - IM fibroblast culture
49 40 http://hl7.org/fhir/sid/cvx Hib (PRP-OMP) rabies, intradermal injection
50 18 http://hl7.org/fhir/sid/cvx DTaP-Hib rabies, intramuscular injection
51 90 http://hl7.org/fhir/sid/cvx Hib-Hep B rabies, unspecified formulation
52 72 http://hl7.org/fhir/sid/cvx Hep A, adult rheumatic fever
53 159 http://hl7.org/fhir/sid/cvx typhoid, parenteral, AKD (U.S. military) Rho(D) - Unspecified formulation
54 157 http://hl7.org/fhir/sid/cvx adenovirus, type 4 Rho(D) -IG IM
55 156 http://hl7.org/fhir/sid/cvx adenovirus, type 7 Rho(D)-IG
56 73 http://hl7.org/fhir/sid/cvx dengue Rift Valley fever
57 34 http://hl7.org/fhir/sid/cvx hantavirus RIG
58 119 http://hl7.org/fhir/sid/cvx Hep C rotavirus, monovalent
59 116 http://hl7.org/fhir/sid/cvx Hep E rotavirus, pentavalent
60 74 http://hl7.org/fhir/sid/cvx herpes simplex 2 rotavirus, tetravalent
61 122 http://hl7.org/fhir/sid/cvx HIV rotavirus, unspecified formulation
62 71 http://hl7.org/fhir/sid/cvx HPV, quadrivalent RSV-IGIV
63 93 http://hl7.org/fhir/sid/cvx Junin virus RSV-MAb
64 145 http://hl7.org/fhir/sid/cvx leishmaniasis RSV-MAb (new)
65 06 http://hl7.org/fhir/sid/cvx leprosy rubella
66 38 http://hl7.org/fhir/sid/cvx Lyme disease rubella/mumps
67 76 http://hl7.org/fhir/sid/cvx malaria Staphylococcus bacterio lysate
68 138 http://hl7.org/fhir/sid/cvx melanoma Td (adult)
69 09 http://hl7.org/fhir/sid/cvx parainfluenza-3 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
70 113 http://hl7.org/fhir/sid/cvx Q fever Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
71 139 http://hl7.org/fhir/sid/cvx RSV-IGIV Td(adult) unspecified formulation
72 115 http://hl7.org/fhir/sid/cvx rheumatic fever Tdap
73 180 http://hl7.org/fhir/sid/cvx Rift Valley fever tetanus immune globulin
74 35 http://hl7.org/fhir/sid/cvx rotavirus, tetravalent tetanus toxoid, adsorbed
75 142 http://hl7.org/fhir/sid/cvx vaccinia (smallpox) tetanus toxoid, not adsorbed
76 112 http://hl7.org/fhir/sid/cvx Staphylococcus bacterio lysate tetanus toxoid, unspecified formulation
77 http://hl7.org/fhir/sid/cvx tick-borne encephalitis
78 13 http://hl7.org/fhir/sid/cvx tularemia vaccine TIG
79 98 http://hl7.org/fhir/sid/cvx vaccinia immune globulin TST, unspecified formulation
80 95 http://hl7.org/fhir/sid/cvx VEE, live TST-OT tine test
801 96 http://hl7.org/fhir/sid/cvx AS03 Adjuvant TST-PPD intradermal
81 97 http://hl7.org/fhir/sid/cvx VEE, inactivated TST-PPD tine test
82 78 http://hl7.org/fhir/sid/cvx adenovirus, unspecified formulation tularemia vaccine
83 190 http://hl7.org/fhir/sid/cvx Hep A, ped/adol, 2 dose Typhoid conjugate vaccine (TCV)
25 http://hl7.org/fhir/sid/cvx typhoid, oral
84 41 http://hl7.org/fhir/sid/cvx Hep A, ped/adol, 3 dose typhoid, parenteral
53 http://hl7.org/fhir/sid/cvx typhoid, parenteral, AKD (U.S. military)
85 91 http://hl7.org/fhir/sid/cvx Hep A, typhoid, unspecified formulation
86 101 http://hl7.org/fhir/sid/cvx IG typhoid, ViCPs
87 131 http://hl7.org/fhir/sid/cvx IGIV typhus, historical
88 75 http://hl7.org/fhir/sid/cvx influenza, unspecified formulation vaccinia (smallpox)
89 105 http://hl7.org/fhir/sid/cvx polio, unspecified formulation vaccinia (smallpox) diluted
90 79 http://hl7.org/fhir/sid/cvx rabies, unspecified formulation vaccinia immune globulin
21 http://hl7.org/fhir/sid/cvx varicella
91 81 http://hl7.org/fhir/sid/cvx typhoid, unspecified formulation VEE, inactivated
80 http://hl7.org/fhir/sid/cvx VEE, live
92 http://hl7.org/fhir/sid/cvx VEE, unspecified formulation
93 36 http://hl7.org/fhir/sid/cvx RSV-MAb VZIG
94 117 http://hl7.org/fhir/sid/cvx MMRV VZIG (IND)
95 37 http://hl7.org/fhir/sid/cvx TST-OT tine test yellow fever
96 183 http://hl7.org/fhir/sid/cvx TST-PPD intradermal Yellow fever vaccine - alt
97 184 http://hl7.org/fhir/sid/cvx TST-PPD tine test Yellow fever, unspecified formulation
98 121 http://hl7.org/fhir/sid/cvx TST, unspecified formulation zoster live
99 187 http://hl7.org/fhir/sid/cvx RESERVED - do not use zoster recombinant
188 http://hl7.org/fhir/sid/cvx zoster, unspecified formulation
998 http://hl7.org/fhir/sid/cvx no vaccine administered
99 http://hl7.org/fhir/sid/cvx RESERVED - do not use
999 http://hl7.org/fhir/sid/cvx unknown
AGRPAL urn:oid:1.2.36.1.2001.1005.17 Agrippal
AVAXM urn:oid:1.2.36.1.2001.1005.17 Avaxim
BCG urn:oid:1.2.36.1.2001.1005.17 BCG
CDT urn:oid:1.2.36.1.2001.1005.17 CDT
CMX urn:oid:1.2.36.1.2001.1005.17 COMVAX
DTP urn:oid:1.2.36.1.2001.1005.17 Triple Antigen
DTPA urn:oid:1.2.36.1.2001.1005.17 DTPa
ENGP urn:oid:1.2.36.1.2001.1005.17 Engerix B
FLRIX urn:oid:1.2.36.1.2001.1005.17 Fluarix
FLUVAX urn:oid:1.2.36.1.2001.1005.17 Fluvax
FLVRN urn:oid:1.2.36.1.2001.1005.17 Fluvirin
FVXJNR urn:oid:1.2.36.1.2001.1005.17 Fluvax Junior
GNDIP urn:oid:1.2.36.1.2001.1005.17 Diphtheria
GNFLU urn:oid:1.2.36.1.2001.1005.17 Influenza
GNHEP urn:oid:1.2.36.1.2001.1005.17 Hepatitis B
GNHIB urn:oid:1.2.36.1.2001.1005.17 HIB
GNHPA urn:oid:1.2.36.1.2001.1005.17 Hepatitis A
GNJEN urn:oid:1.2.36.1.2001.1005.17 Japanese Encephalitis
GNMEA urn:oid:1.2.36.1.2001.1005.17 Measles
GNMEN urn:oid:1.2.36.1.2001.1005.17 Meningococcal C
GNMUM urn:oid:1.2.36.1.2001.1005.17 Mumps
GNPNE urn:oid:1.2.36.1.2001.1005.17 Pneumococcal
GNPOL urn:oid:1.2.36.1.2001.1005.17 Polio
GNROX urn:oid:1.2.36.1.2001.1005.17 Rotavirus
GNRUB urn:oid:1.2.36.1.2001.1005.17 Rubella
GNTET urn:oid:1.2.36.1.2001.1005.17 Tetanus
GNVAR urn:oid:1.2.36.1.2001.1005.17 Varicella
HATWNJ urn:oid:1.2.36.1.2001.1005.17 Twinrix Junior
HAVAQ urn:oid:1.2.36.1.2001.1005.17 Vaqta Paed/Adol
HAVJ urn:oid:1.2.36.1.2001.1005.17 Havrix Junior
HBOC urn:oid:1.2.36.1.2001.1005.17 HibTITER
HBV urn:oid:1.2.36.1.2001.1005.17 HBV
HBVP urn:oid:1.2.36.1.2001.1005.17 HBVAX II
HBX urn:oid:1.2.36.1.2001.1005.17 Hiberix
IFHX urn:oid:1.2.36.1.2001.1005.17 Infanrix Hexa
IFIP urn:oid:1.2.36.1.2001.1005.17 Infanrix-IPV
IFPA urn:oid:1.2.36.1.2001.1005.17 Infanrix Penta
IFX urn:oid:1.2.36.1.2001.1005.17 Infanrix
IFXB urn:oid:1.2.36.1.2001.1005.17 InfanrixHepB
INFLUV urn:oid:1.2.36.1.2001.1005.17 Influvac
IPV urn:oid:1.2.36.1.2001.1005.17 IPOL
JEVAX urn:oid:1.2.36.1.2001.1005.17 JE-VAX
MENJUG urn:oid:1.2.36.1.2001.1005.17 Menjugate
MENTEC urn:oid:1.2.36.1.2001.1005.17 Meningitec
MENUME urn:oid:1.2.36.1.2001.1005.17 Menomune
MENVAX urn:oid:1.2.36.1.2001.1005.17 Mencevax ACWY
MMR urn:oid:1.2.36.1.2001.1005.17 MMR
MMRCSL urn:oid:1.2.36.1.2001.1005.17 MMR II
MMRSKB urn:oid:1.2.36.1.2001.1005.17 Priorix
MNTRX urn:oid:1.2.36.1.2001.1005.17 Menitorix
NEISVC urn:oid:1.2.36.1.2001.1005.17 NeisVac-C
OPV urn:oid:1.2.36.1.2001.1005.17 Polio
P urn:oid:1.2.36.1.2001.1005.17 Pertussis
PANVAX urn:oid:1.2.36.1.2001.1005.17 Panvax
PDCL urn:oid:1.2.36.1.2001.1005.17 Pediacel
PLCL urn:oid:1.2.36.1.2001.1005.17 Poliacel
PNEUMO urn:oid:1.2.36.1.2001.1005.17 Pneumovax
PRPD urn:oid:1.2.36.1.2001.1005.17 ProHIBit
PROQAD urn:oid:1.2.36.1.2001.1005.17 ProQuad
PRPOMP urn:oid:1.2.36.1.2001.1005.17 PedvaxHIB
PRPT urn:oid:1.2.36.1.2001.1005.17 ActHIB
PRVNR urn:oid:1.2.36.1.2001.1005.17 Prevenar 7
PRVTH urn:oid:1.2.36.1.2001.1005.17 Prevenar 13
PRXTEX urn:oid:1.2.36.1.2001.1005.17 Priorix-Tetra
QDCL urn:oid:1.2.36.1.2001.1005.17 Quadracel
ROTRIX urn:oid:1.2.36.1.2001.1005.17 Rotarix
ROTTEQ urn:oid:1.2.36.1.2001.1005.17 Rotateq
SYNFLX urn:oid:1.2.36.1.2001.1005.17 Synflorix
TCL urn:oid:1.2.36.1.2001.1005.17 Tripacel
VAXGRP urn:oid:1.2.36.1.2001.1005.17 Vaxigrip
VGRJNR urn:oid:1.2.36.1.2001.1005.17 Vaxigrip Junior
VLRIX urn:oid:1.2.36.1.2001.1005.17 Varilrix
VRVAX urn:oid:1.2.36.1.2001.1005.17 Varivax

 

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

Level Lvl A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes For value sets, levels are under other codes, and imply that the mostly used to organize codes for user convenience, but may follow code they are under also applies system hierarchy - see Code System for further information
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
Display The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code